๐ฌ Editorial: Global #HeartFailure prevalence has increased substantially, and better prevention of hypertension, ischemic heart disease, and rheumatic heart disease may help reduce future burden.

๐ฌ Editorial: Global #HeartFailure prevalence has increased substantially, and better prevention of hypertension, ischemic heart disease, and rheumatic heart disease may help reduce future burden.
Globally, #HeartFailure affected an estimated 56 million people in 2023, with increasing burden largely associated with population growth and aging.
Every advance in #HeartFailure (HF) care reshapes survival.
Nutrition is not adjunctive but essential. Integrating assessment and intervention into HF pathways improves therapy delivery, outcomes, and prognosis. #medsky #Cardiology
#CVIA #OpenAccess: doi.org/10.15212/CVI...
PMA approval is the FDA's most rigorous pathway, Class III territory, where every claim has to clear a clinical trial. Cardio-HART doesn't sit there; the diagnostic side travels a different regulatory road.
cool tech, but my folks can't reach a cath lab.
๐ The future of care starts with the science we share today.
Share your work at #THT2027 and join the community advancing the next generation of #heartfailure treatment.
โฑ๏ธ Submit by the Early Notification Deadline of 10/1 and receive a decision within 1 week. https://ow.ly/m31x50ZSRE7
๐ #CallforPapers | #NewSpecialIssue
โค ๐๐ฎ๐ฟ๐ฑ๐ถ๐ฎ๐ฐ ๐๐ถ๐ฏ๐ฟ๐ผ๐๐ถ๐: ๐ฆ๐ถ๐ด๐ป๐ฎ๐น๐ถ๐ป๐ด ๐ฃ๐ฎ๐๐ต๐๐ฎ๐๐, ๐๐บ๐บ๐๐ป๐ฒ ๐ฅ๐ฒ๐ด๐๐น๐ฎ๐๐ถ๐ผ๐ป, ๐๐ฒ๐น๐น๐๐น๐ฎ๐ฟ ๐๐ฟ๐ผ๐๐๐๐ฎ๐น๐ธ ๐ฎ๐ป๐ฑ ๐ ๐๐ผ๐ฐ๐ฎ๐ฟ๐ฑ๐ถ๐ฎ๐น ๐๐๐๐ณ๐๐ป๐ฐ๐๐ถ๐ผ๐ป
๐ฅ Guest Editors: Dr. David Schumacher | Dr. Moritz Uhlig
#CellsMDPI #CardiacFibrosis #HeartFailure #FibroblastBiology
This #WorldHeartDay, The Heart Hub has launched a brand-new patient & caregiver guide for #HeartFailure with non-reduced ejection fraction. ๐ซ
Find the latest info on #LivingWithHF, including recommended medications & ways to enhance your quality of life: ourhearthub.ca/heart-failur...
This World Heart Day, build your confidence in optimising the four pillars. ๐
Our Heart failure Optimise programme supports knowledge, skills and confidence in heart failure care, with patient experience built into the learning.
new DEB approval caught my eye, shorter DAPT windows would actually change something I see weekly, most bleeds I refer are over-75s on dual therapy. Whether Stockport ICB funds SELUTION before I retire is the more relevant question.
low prevalence absolutely murders PPV even with decent sens/spec, NPV's the only thing keeping me sane before I send someone to a 14-week echo waitlist. Anyone else actually run the pre-test prob in their head or just go on clinical hunch?...
Congratulations to Stian on this AMRF award for presenting his research in heart failure and contributing to important conversations in cardiovascular research at 2026's HealtheX.
Read more:
www.linkedin.com/feed/update/...
#cardiovascular #medicalresearch #healthresearch #heartfailure
Can one gut microbe reshape how we approach heart failure? ๐ฆ ๐ซ
New research spotlights Bifidobacterium, linking higher levels to milder disease and better heart function. www.news-medical.net/news/2026092... #GutHealth #HeartFailure #Microbiome
Wanna hear some bullshit?
Bcuz of my #heartfailure #HfpEF I suffer from low oxygen at higher elevations like Denver (๐) esp. at night. But my doctor canโt prescribe supplemental O2 for travel w/O a sleep test being done at the locations Iโm traveling to. Stupid, eh?
Capability at the front door doesn't shrink the referral queue, it decides who belongs in it, which is the question Cardio-HART is built to inform.
Thoracic catheter Class II recall, bacterial endotoxin OOS in one lot. Checking which post-cardiothoracic patients got that lot. 14-week echo queue but device alerts land same-day.
Day 2 at #PCCS2026 starts with heart failure: think HF earlier, use NT-proBNP to support diagnosis, code the phenotype accurately and optimise treatment promptly.
For HFrEF, think four pillars and early action.
Can EV miRNAs redefine cardiac care?
Multi-omics integration, sensitive detection & intelligent delivery make EV miRNA interventions the frontier of personalized medicine, from #MyocardialInfarction to #HeartFailure. #medsky #Cardiology
#CVIA #OpenAccess: doi.org/10.15212/CVI...
Pharmacovigilance
Distinct pattern of reported adverse event with SGLT2 inhibitors in heart failure: A pharmacovigilance study using VigiBase data
#SGLT-2Inhibitors #ADRs #Pharmacovigilance #HeartFailure #Type2DiabetesMellitus
www.em-consulte.com/article/1840...